[PHARMA] YoY Cumulative Quarter Result on 30-Sep-2018 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
19-Nov-2018
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2018
Quarter
30-Sep-2018 [#3]
Profit Trend
QoQ- 65.5%
YoY- 18.76%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
Revenue 4,103,297 2,090,488 2,104,847 1,788,312 1,710,764 1,606,206 1,509,162 18.12%
PBT 151,987 49,299 46,609 58,280 53,198 67,948 89,005 9.31%
Tax -64,947 -15,983 -17,323 -19,620 -20,299 -21,189 -20,462 21.20%
NP 87,040 33,316 29,286 38,660 32,899 46,759 68,543 4.05%
-
NP to SH 86,675 33,820 29,379 38,031 32,023 46,435 67,982 4.12%
-
Tax Rate 42.73% 32.42% 37.17% 33.67% 38.16% 31.18% 22.99% -
Total Cost 4,016,257 2,057,172 2,075,561 1,749,652 1,677,865 1,559,447 1,440,619 18.61%
-
Net Worth 391,428 345,040 516,387 522,618 531,892 530,907 534,070 -5.04%
Dividend
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
Div 56,292 26,139 22,168 36,401 33,729 33,667 59,542 -0.93%
Div Payout % 64.95% 77.29% 75.46% 95.71% 105.33% 72.50% 87.59% -
Equity
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
Net Worth 391,428 345,040 516,387 522,618 531,892 530,907 534,070 -5.04%
NOSH 1,309,126 261,705 261,229 260,505 259,821 258,979 258,880 30.98%
Ratio Analysis
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
NP Margin 2.12% 1.59% 1.39% 2.16% 1.92% 2.91% 4.54% -
ROE 22.14% 9.80% 5.69% 7.28% 6.02% 8.75% 12.73% -
Per Share
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
RPS 313.44 799.75 807.07 687.79 659.36 620.21 582.96 -9.81%
EPS 6.62 12.94 11.26 14.63 12.34 17.93 26.26 -20.50%
DPS 4.30 10.00 8.50 14.00 13.00 13.00 23.00 -24.36%
NAPS 0.299 1.32 1.98 2.01 2.05 2.05 2.063 -27.50%
Adjusted Per Share Value based on latest NOSH - 260,505
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
RPS 284.71 145.05 146.05 124.08 118.70 111.45 104.71 18.12%
EPS 6.01 2.35 2.04 2.64 2.22 3.22 4.72 4.10%
DPS 3.91 1.81 1.54 2.53 2.34 2.34 4.13 -0.90%
NAPS 0.2716 0.2394 0.3583 0.3626 0.3691 0.3684 0.3706 -5.04%
Price Multiplier on Financial Quarter End Date
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
Date 30/09/21 30/09/20 30/09/19 28/09/18 29/09/17 30/09/16 30/09/15 -
Price 0.835 4.32 2.44 2.89 4.14 5.58 6.50 -
P/RPS 0.27 0.54 0.30 0.42 0.63 0.90 1.12 -21.09%
P/EPS 12.61 33.39 21.66 19.76 33.54 31.12 24.75 -10.62%
EY 7.93 2.99 4.62 5.06 2.98 3.21 4.04 11.88%
DY 5.15 2.31 3.48 4.84 3.14 2.33 3.54 6.44%
P/NAPS 2.79 3.27 1.23 1.44 2.02 2.72 3.15 -2.00%
Price Multiplier on Announcement Date
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
Date 19/11/21 19/11/20 20/11/19 19/11/18 15/11/17 21/11/16 26/11/15 -
Price 0.845 5.72 2.21 3.09 3.82 5.70 6.50 -
P/RPS 0.27 0.72 0.27 0.45 0.58 0.92 1.12 -21.09%
P/EPS 12.76 44.21 19.62 21.13 30.95 31.79 24.75 -10.44%
EY 7.84 2.26 5.10 4.73 3.23 3.15 4.04 11.67%
DY 5.09 1.75 3.85 4.53 3.40 2.28 3.54 6.23%
P/NAPS 2.83 4.33 1.12 1.54 1.86 2.78 3.15 -1.76%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment